Kyverna Therapeutics Balance Sheet (2023-2026) | KYTX

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 39.79M53.43M22.97M34.65M224.29M131.62M104.66M96.62M56.87M52.10M34.16M124.09M28.70M
Short-term Investments (Quarter) 22.90M145.51M214.62M216.92M189.36M185.78M158.24M137.00M155.16M204.25M
Cash & Current Investments (Quarter) 39.79M53.43M22.97M57.54M369.79M346.24M321.59M285.98M242.65M210.34M171.16M279.25M232.95M
Prepaid Assets (Quarter) 3.12M5.69M2.59M3.79M4.62M5.00M2.65M3.79M3.70M5.28M
Current Assets (Quarter) 60.66M375.49M348.82M325.37M290.60M247.65M214.33M174.93M282.95M241.73M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 2.33M2.71M3.37M3.15M3.35M2.44M2.16M1.79M1.55M1.34M
Other Non-Current Assets (Quarter) 0.60M0.57M0.57M1.88M0.60M0.56M4.05M0.55M4.90M5.01M
Non-Current Assets (Quarter) 14.53M14.50M14.29M13.82M14.04M13.00M12.18M12.23M10.87M15.30M
Assets (Quarter) 75.19M389.98M363.12M339.20M304.64M260.65M226.51M187.16M293.83M257.02M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 4.36M7.45M4.86M9.93M4.62M8.47M9.92M3.02M5.31M11.60M
Payables (Quarter) 4.36M7.45M4.86M9.93M4.62M8.47M9.92M3.02M5.31M11.60M
Accumulated Expenses (Quarter) 2.81M1.36M2.72M4.44M4.88M3.08M4.97M6.96M9.99M3.11M
Other Accumulated Expenses (Quarter) 1.79M2.90M1.76M1.23M2.04M2.17M3.02M
Current Leases (Quarter) 1.96M2.74M2.87M3.00M3.16M3.08M3.28M0.19M0.31M1.76M
Total Current Liabilities (Quarter) 19.86M21.86M23.48M30.98M33.76M33.29M39.79M33.87M36.49M29.67M
Non-Current Liabilities
Capital Leases (Quarter) 0.92M0.67M0.41M0.24M0.14M0.07M0.03M0.01M
Non-Current Debt (Quarter) 24.74M24.81M
Preferred Stock Liabilities (Quarter) 120.67M145.73M180.57M180.57M
Operating Leases (Quarter) 5.24M6.46M5.72M4.97M4.16M3.28M2.32M1.33M0.32M6.96M
Other Non-Current Liabilities (Quarter) 0.30M
Total Non-Current Liabilities (Quarter) 36.19M
Total Liabilities (Quarter) 84.61M97.19M111.81M26.02M28.99M29.61M36.49M38.06M36.65M42.13M35.21M61.55M61.44M
Shareholder's Equity
Total Debt (Quarter) 24.74M24.81M
Common Equity (Quarter) -84.61M-97.19M-111.81M-13.14M360.99M333.51M302.71M266.59M224.01M184.38M151.95M232.28M195.58M
Shareholder's Equity (Quarter) -84.61M-97.19M-111.81M-13.14M360.99M333.51M302.71M266.59M224.01M184.38M151.95M232.28M195.58M
Liabilities and Shareholders Equity (Quarter) 75.19M389.98M363.12M339.20M304.64M260.65M226.51M187.16M293.83M257.02M
Retained Earnings (Quarter) -136.04M-0.00M-191.54M-226.00M0.10M-0.00M-0.02M0.03M-424.83M-464.60M
Treasury Shares (Quarter) 0.01M0.55M0.64M1.25M1.29M1.18M0.02M